Stock Track | Tilray Inc. Soars 42.11% Intraday on Reports of Trump's Plan to Loosen Marijuana Restrictions

Stock Track12-12

Tilray Inc. (TLRY) surged 42.11% during intraday trading on Friday, marking one of the stock's most significant single-day gains. The sharp rise follows reports that President Donald Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, a move that would ease federal restrictions on the cannabis industry.

The potential policy shift would place marijuana in the same category as substances like ketamine and Tylenol with codeine, reducing regulatory hurdles and tax burdens for cannabis companies. Additionally, Tilray's recent launch of its new Amped Live Resin Liquid Diamond vape product under the Redecan brand has further fueled investor optimism.

Analysts note that the reclassification could open up new opportunities for Tilray and other cannabis firms, including improved access to banking services and increased medical research funding. The news has sparked a broader rally in cannabis stocks, with peers like Canopy Growth and Aurora Cannabis also posting double-digit gains.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1118499378?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118499378","market":"sg","top_or_hot":-1,"title":"Stock Track | Tilray Inc. Soars 42.11% Intraday on Reports of Trump's Plan to Loosen Marijuana Restrictions","media":"Stock Track","content":"<p>Tilray Inc. (TLRY) surged 42.11% during intraday trading on Friday, marking one of the stock's most significant single-day gains. The sharp rise follows reports that President Donald Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, a move that would ease federal restrictions on the cannabis industry.</p><p>The potential policy shift would place marijuana in the same category as substances like ketamine and Tylenol with codeine, reducing regulatory hurdles and tax burdens for cannabis companies. Additionally, Tilray's recent launch of its new Amped Live Resin Liquid Diamond vape product under the Redecan brand has further fueled investor optimism.</p><p>Analysts note that the reclassification could open up new opportunities for Tilray and other cannabis firms, including improved access to banking services and increased medical research funding. The news has sparked a broader rally in cannabis stocks, with peers like Canopy Growth and Aurora Cannabis also posting double-digit gains.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tilray Inc. Soars 42.11% Intraday on Reports of Trump's Plan to Loosen Marijuana Restrictions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tilray Inc. Soars 42.11% Intraday on Reports of Trump's Plan to Loosen Marijuana Restrictions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-12 22:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tilray Inc. (TLRY) surged 42.11% during intraday trading on Friday, marking one of the stock's most significant single-day gains. The sharp rise follows reports that President Donald Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, a move that would ease federal restrictions on the cannabis industry.</p><p>The potential policy shift would place marijuana in the same category as substances like ketamine and Tylenol with codeine, reducing regulatory hurdles and tax burdens for cannabis companies. Additionally, Tilray's recent launch of its new Amped Live Resin Liquid Diamond vape product under the Redecan brand has further fueled investor optimism.</p><p>Analysts note that the reclassification could open up new opportunities for Tilray and other cannabis firms, including improved access to banking services and increased medical research funding. The news has sparked a broader rally in cannabis stocks, with peers like Canopy Growth and Aurora Cannabis also posting double-digit gains.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"","article_id":"1118499378","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118499378","pubTimestamp":1765550073,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tilray Inc. (TLRY) surged 42.11% during intraday trading on Friday, marking one of the stock's most significant single-day gains. The sharp rise follows reports that President Donald Trump is...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"个股追踪|Tilray Inc.盘中大涨42.11%因特朗普计划放松大麻限制报道","themeId":"3aeb3334bd8dd5b081b78a6ca75d43d4","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":1},"content_text":"Tilray Inc. (TLRY) surged 42.11% during intraday trading on Friday, marking one of the stock's most significant single-day gains. The sharp rise follows reports that President Donald Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, a move that would ease federal restrictions on the cannabis industry.The potential policy shift would place marijuana in the same category as substances like ketamine and Tylenol with codeine, reducing regulatory hurdles and tax burdens for cannabis companies. Additionally, Tilray's recent launch of its new Amped Live Resin Liquid Diamond vape product under the Redecan brand has further fueled investor optimism.Analysts note that the reclassification could open up new opportunities for Tilray and other cannabis firms, including improved access to banking services and increased medical research funding. The news has sparked a broader rally in cannabis stocks, with peers like Canopy Growth and Aurora Cannabis also posting double-digit gains.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118499378","isCrawlerRequest":true}